JCRB3075 MK-7

Cell information

Cell type:human mutant cell repository from Kyoto University (View Pricing Information)

JCRB No.   JCRB3075 Cell Name   MK-7
Profile   Congenital anomaly (Mutant karyotype) D-trisomy Other Name   
Animal   human Strain   
Genus   Homo Species   sapiens
Sex    Age   
Identity   available Tissue for Primary Cancer   
Case history   Congenital anomaly (Mutant karyotype) Metastasis   
Tissue Metastasized    Genetics   D-trisomy
Life Span    Crisis PDL   
Morphology    Character   
Classify   primary Established by   
Registered by   Radiation Biology Center, Kyoto University Regulation for Distribution   
Comment    Year   
Medium    Methods for Passages   
Cell Number on Passage    Race   
CO2 Conc.    Tissue Sampling   
Tissue Type   

Detection of virus genome fragment by Real-time PCR
Detected DNA Virus tested Detected RNA Virus tested
CMV - parvoB19 - HCV - HTLV-1 -
EBV - HBV - HIV-1 - HTLV-2 -
HHV6 - HTLV-1 - HIV-2 - HAV -
HHV7 - HTLV-2 - -/negative.
+/positive.
nt/not tested.
(positive (+) does not immediately mean the production of infectious viral particles.)
BKV - HIV-1 -
JCV - HIV-2 -
ADV - HPV18 -
Notes

Movies



LOT Information

Cell No.   JCRB3075 Cell Name   MK-7
LOT No.   12082022 Lot Specification   distribution
Medium   RPMI1640(GIBCO Cat#11875-093) with 20% fetal bovine serum (SIGMA, Cat#172012, Lot#12J396,non HI) Temperature   37 C
Cell Density at Seeding   2.42-3.94x10^4 cells/sq.cm Methods for Passages   Cells were harvested after treatment with 0.25%trypsin(GIBCO) and 0.02% EDTA.
Doubling Time   NT Cell Number in Vial (cells/1ml)   1.38x10^6
Viability at cell freezing (%)   99 Antibiotics Used   free
Passage Number   p9 PDL   NT
Sterility: MYCOPLASMA   - Sterility: BACTERIA   -
Sterility: FUNGI   - Isozyme Analysis   
Chromosome Mode   NT Chromosome Information   NT
Surface Antigen   NT DNA Profile (STR)   D5S818:11,13
D13S317:8,9,13
D7S820:8,11
D16S539:9,10
VWA:17,18
TH01:6,7
AM:X,Y
TPOX:8,11
CSF1PO:13,14
Adhesion   Yes Exoteric Gene   NT
Medium for Freezing   BAMBANKER (LYMPHOTEC Inc., CS-02-001, NIPPON Genetics Co., LTD) CO2 Conc.   5%
Viability immediately after thawing (%)   99 Additional information   
CLOSE